INNOSPEC INC.
For the period ended Mar 31, 2026. Filed May 8, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 8, 2026
IOSP$77.72-3.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Three Months EndedMarch 31, | ||
|---|---|---|
| (in millions) | 2026 | 2025 |
| Cash Flows from Operating Activities | ||
| Net income attributable to Innospec | $30.4 | $32.8 |
| Adjustments to reconcile net income attributable to Innospec to net cash provided by operating activities: | ||
| Depreciation and amortization | 9.9 | 10.9 |
| Adjustment to fair value of contingent consideration | (4.7) | 0.7 |
| Deferred taxes | (0.7) | (0.3) |
| Profit on disposal of property, plant and equipment | — | (0.1) |
| Movements on defined benefit pension plans | (0.2) | 1.3 |
| Stock option compensation | 1.6 | 1.9 |
| Changes in assets and liabilities, net of effects of acquired and divested companies: | ||
| Trade and other accounts receivable | (13.7) | 6.6 |
| Inventories | 5.9 | (6.6) |
| Prepaid expenses | 3.2 | 5.4 |
| Accounts payable and accrued liabilities | (17.7) | (27.0) |
| Plant closure provisions | 1.5 | (0.4) |
| Income taxes | 0.4 | 4.3 |
| Other assets and liabilities | 1.7 | (1.2) |
| Net cash provided by operating activities | 17.6 | 28.3 |
| Cash Flows from Investing Activities | ||
| Capital expenditures | (8.9) | (8.4) |
| Internally developed software | (5.1) | (7.2) |
| Proceeds on disposal of property, plant and equipment | 0.3 | 0.1 |
| Net cash used in investing activities | (13.7) | (15.5) |
| Cash Flows from Financing Activities | ||
| Non-controlling interest | 0.4 | 0.8 |
| Issue of treasury stock | 0.1 | 0.2 |
| Repurchase of common stock | (7.1) | (4.8) |
| Net cash used in financing activities | (6.6) | (3.8) |
| Effect of foreign currency exchange rate changes on cash | (0.7) | 1.6 |
| Net change in cash and cash equivalents | (3.4) | 10.6 |
| Cash and cash equivalents at beginning of period | 292.5 | 289.2 |
| Cash and cash equivalents at end of period | $289.1 | $299.8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.